Speech-Language Pathologists in Tequesta, FL Accepting Medicare

17 Speech-Language Pathologists found. Showing 1 - 17

Mrs. Julie Thill Stellman, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr, 11 E, Tequesta, FL 33469 Phone: 561-747-8188    Fax: 561-747-8388

Lindsay Snyder Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 169 Tequesta Drive, Suite 24e, Tequesta, FL 33469 Phone: 561-747-8188

Kayla Henry Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr Ste 24e, Tequesta, FL 33469 Phone: 561-747-8188

Caroline Rose Agostino, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr Ste 24e, Tequesta, FL 33469 Phone: 561-747-8188

Ashley Brooks Ramos, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8738 Se Riverfront Ter, Tequesta, FL 33469 Phone: 904-316-7300

Julie A Daniels-scott, M.ED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19275 Caribbean Ct, Tequesta, FL 33469 Phone: 561-662-2803

Mrs. Remai Jacqueline Eckhardt, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr, Suite 24e, Tequesta, FL 33469 Phone: 561-747-8188    Fax: 561-747-8388

Sofia Tzavaras Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19823 Gardenia Dr, Tequesta, FL 33469 Phone: 407-694-5758

Benee Benardo, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 400 N Us Highway 1, Tequesta, FL 33469 Phone: 561-207-6500

Mary Hoyer, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 N Us Highway 1, Tequesta, FL 33469 Phone: 770-668-4726

Valerie A Alfera, SLP/CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr, Suite 24e, Tequesta, FL 33469 Phone: 561-747-8188    Fax: 561-747-8388

Ms. Maxine Krynauw, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr Ste 24e, Tequesta, FL 33469 Phone: 561-747-8188

Hannah Fennell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Drive, Suite 24e, Tequesta, FL 33469 Phone: 561-747-8188

Ms. Leslie Leigh Mccrudden, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 72 Azalea Cir, Tequesta, FL 33469 Phone: 561-350-1949

Shannon Watts, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr, Suite 24e, Tequesta, FL 33469 Phone: 772-215-3335    Fax: 772-287-0723

Raquel Fleming, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 169 Tequesta Dr, Suite 24e, Tequesta, FL 33469 Phone: 561-747-8188

Amanda Roach, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 46 Chapel Ct, Tequesta, FL 33469 Phone: 315-771-2140

News Archive

Women have lower tolerance to alcohol following gastric sleeve surgery, study finds

Women who have had gastric sleeve surgery to lose weight may want to consider limiting the number of alcoholic drinks they consume post-surgery.

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

"Sony Corporation and the Global Fund to Fight AIDS, Tuberculosis and Malaria have entered into a partnership for the implementation of behavior change projects, in which Sony provides state of the art equipment and movies and the Global Fund ensures it gets to agencies best able to reach communities most in need," a Global Fund press release states, noting, "This partnership is the first pilot case that combines pro bono and in-kind contribution."

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

Judge blocks federal funding of human embryonic stem cell research

The Washington Post: "A federal judge on Monday blocked the Obama administration from funding human embryonic stem cell research, ruling that the support violates a federal law barring the use of taxpayer money for experiments that destroy human embryos.

Read more Medical News

› Verified 9 days ago